Acura Pharmaceuticals, Inc. (ACUR)

Market Cap	6.73K -74.7%
Revenue (ttm)	1.56M -56.2%
Net Income	-879.00K
EPS	-0.02
Shares Out	66.65M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	34,348
Open	0.000101
Previous Close	n/a
Day's Range	0.000101 - 0.000101
52-Week Range	0.000001 - 0.0020
Beta	52.26
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Acura Pharmaceuticals

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1935
• Employees: 9
• Stock Exchange: OTCMKTS
• Ticker Symbol: ACUR

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 9, 2026

Data Sources Report a data error